Shares of Danaher Co. (NYSE:DHR) have received a consensus recommendation of “Buy” from the sixteen ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and fifteen have given a buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $111.61.
A number of equities analysts have commented on DHR shares. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $119.00 price objective for the company in a research report on Wednesday, September 19th. Morgan Stanley lifted their target price on Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a report on Wednesday, October 10th. Finally, Robert W. Baird dropped their target price on Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a report on Friday, October 19th.
DHR stock traded up $0.87 during midday trading on Monday, reaching $103.28. 2,026,722 shares of the company were exchanged, compared to its average volume of 2,422,748. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.53 and a quick ratio of 1.08. Danaher has a one year low of $91.84 and a one year high of $110.13. The stock has a market cap of $71.78 billion, a price-to-earnings ratio of 25.63, a price-to-earnings-growth ratio of 1.97 and a beta of 1.04.
In related news, insider William King sold 53,433 shares of the business’s stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $101.64, for a total value of $5,430,930.12. Following the completion of the transaction, the insider now owns 36,425 shares of the company’s stock, valued at $3,702,237. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Robert S. Lutz sold 15,000 shares of the business’s stock in a transaction dated Wednesday, November 7th. The shares were sold at an average price of $103.80, for a total value of $1,557,000.00. Following the completion of the transaction, the senior vice president now directly owns 33,044 shares of the company’s stock, valued at approximately $3,429,967.20. The disclosure for this sale can be found here. Insiders have sold 150,007 shares of company stock valued at $15,202,163 in the last three months. Insiders own 11.90% of the company’s stock.
A number of hedge funds have recently bought and sold shares of the stock. Gardiner Nancy B raised its stake in Danaher by 5.8% during the third quarter. Gardiner Nancy B now owns 9,110 shares of the conglomerate’s stock worth $991,000 after acquiring an additional 500 shares in the last quarter. Reilly Financial Advisors LLC raised its stake in Danaher by 62.6% during the third quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock worth $141,000 after acquiring an additional 501 shares in the last quarter. Securian Asset Management Inc raised its stake in Danaher by 0.8% during the second quarter. Securian Asset Management Inc now owns 62,119 shares of the conglomerate’s stock worth $6,130,000 after acquiring an additional 504 shares in the last quarter. Centaurus Financial Inc. raised its stake in Danaher by 20.3% during the second quarter. Centaurus Financial Inc. now owns 3,026 shares of the conglomerate’s stock worth $299,000 after acquiring an additional 510 shares in the last quarter. Finally, Whitnell & Co. raised its stake in Danaher by 2.1% during the third quarter. Whitnell & Co. now owns 25,270 shares of the conglomerate’s stock worth $2,746,000 after acquiring an additional 514 shares in the last quarter. 77.31% of the stock is owned by institutional investors and hedge funds.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
See Also: What is a capital gain?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.